Nephros (NEPH) Net Income towards Common Stockholders (2016 - 2025)
Nephros has reported Net Income towards Common Stockholders over the past 16 years, most recently at $62000.0 for Q4 2025.
- Quarterly results put Net Income towards Common Stockholders at $62000.0 for Q4 2025, down 82.97% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 1381.71% YoY), and the annual figure for FY2025 was $1.2 million, up 1513.51%.
- Net Income towards Common Stockholders for Q4 2025 was $62000.0 at Nephros, down from $337000.0 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for NEPH hit a ceiling of $579000.0 in Q1 2025 and a floor of -$3.2 million in Q3 2022.
- Median Net Income towards Common Stockholders over the past 5 years was -$369500.0 (2023), compared with a mean of -$588350.0.
- Biggest five-year swings in Net Income towards Common Stockholders: plummeted 240.6% in 2022 and later skyrocketed 428.98% in 2025.
- Nephros' Net Income towards Common Stockholders stood at -$1.1 million in 2021, then increased by 16.77% to -$918000.0 in 2022, then grew by 28.76% to -$654000.0 in 2023, then surged by 155.66% to $364000.0 in 2024, then plummeted by 82.97% to $62000.0 in 2025.
- The last three reported values for Net Income towards Common Stockholders were $62000.0 (Q4 2025), $337000.0 (Q3 2025), and $237000.0 (Q2 2025) per Business Quant data.